Color Genomics

Discussion in 'Labcorp' started by Anonymous, Apr 21, 2015 at 8:44 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    LabCorp-----> The joke is on you!.! Your tests are way OVERPRICED! You wont be able to sell BRCA now.
     

  2. Anonymous

    Anonymous Guest

    For a fraction of the cost of current genetic testing, $249, Color offers comprehensive genetic testing with a “spit kit” ordered online and sent to recipients by mail. After the kits are returned, Color analyzes 19 genes—including BRCA1 and BRCA2, the two gene mutations related to breast and ovarian cancer. After receiving results, testers will be able to get in touch with board-certified genetic counselors at Color about the next steps based on results and a screening prevention plan.

    Silicon Valley venture capitalists and luminaries are betting that Color is going to democratize genetic testing. The startup has raised $15 million in funding from Khosla Ventures, Formation8, Steve Jobs’ wife Laurene Powell Jobs, Cisco chief technology officer Padmasree Warrior, Twitter executive Katie Stanton, Eventbrite co-founder Julia Hartz, Yahoo co-founder Jerry Yang, PayPal co-founder Max Levchin, Dropbox co-founder Drew Houston, and Box co-founder Aaron Levie.

    As Color’s CEO and cofounder Elad Gil explains, the company has taken existing testing processes, and optimized every step. “There are a lot of pieces that can be automated,” he adds.

    For background, Color is a laboratory developed test that is run in Color’s lab under federal regulatory standards that apply to all clinical laboratory testing. Color is a physician-ordered test, similar to other genetic tests for BRCA 1 and BRCA2. Consumers will either need to have their own physician order the test, or ask a Color physician to approve a request for a test.


    Color is currently collaborating with healthcare providers at University of Pennsylvania and University of California at San Francisco. In addition, several notable genetics experts have been collaborating with the company, including Dr. Mary-Claire King, who discovered the BRCA1 gene.

    For Color’s cofounders and team, cancer, and specifically the BRCA1 and BRCA2 gene, are close to home.

    Color is also launching the “Every Woman Program,” which works with cancer centers to provide genetic testing for patients who are unable to afford it.
     
  3. Anonymous

    Anonymous Guest

    $250.00
     
  4. Anonymous

    Anonymous Guest



    For a fraction of the cost of current genetic testing, $249, Color offers comprehensive genetic testing with a spit kit ordered online and sent to recipients by mail. After the kits are returned, Color analyzes 19 genes—including BRCA1 and BRCA2, the two gene mutations related to breast and ovarian cancer. After receiving results, testers will be able to get in touch with board-certified genetic counselors at Color about the next steps based on results and a screening prevention plan.
     
  5. Anonymous

    Anonymous Guest

    Lots of job openings- Just sayin' Silicon Valley
     
  6. Anonymous

    Anonymous Guest

    We hear it all the time its profit over patient care
     
  7. Anonymous

    Anonymous Guest

    Color genomics is a amateurish joke and according to Labcorp’s CEO regarding BRCA testing, "it's not substantial or material in terms of our entire book of business."

    Looks like the joke is on both of you.
     
  8. Anonymous

    Anonymous Guest

    It’s what the Managed Care plans want to pay; you know they will go for the lowest price. If BRCA was not substantial, why did you send so much time, money and man hours trying to launch it with no success? Guess you have to buy a company to compete since you can’t get an advance test up and running by yourselves.
     
  9. anonymous

    anonymous Guest

    I heard the whole SalesForce was shown the door? Why?
     
  10. anonymous

    anonymous Guest

    Labcorp continues to prove that it will go for profit vs. patient care- day in, day out with no exceptions. Many employees have known that for years and we are finally admitting we are sick of it. How many years are we going to sacrifice patients and customers in the fourth quarter just so we look good to Wall Street. The medical community as a whole deserves better than that and my New Year’s resolution is I am going to do what is right for the customer and not Labcorp’s bank account!
     
  11. anonymous

    anonymous Guest